Renaissance Technologies - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$2,205,000
+416.4%
90,700
+433.5%
0.01%
+400.0%
Q4 2014$427,000
-82.9%
17,000
-82.7%
0.00%
-83.3%
Q4 2013$2,500,000
+116.5%
98,500
+74.0%
0.01%
+100.0%
Q3 2013$1,155,000
+439.7%
56,600
+454.9%
0.00%
+200.0%
Q2 2013$214,00010,2000.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 453,392$11,022,0001.89%
GREAT POINT PARTNERS LLC 141,900$3,450,0001.34%
Penn Capital Management Company, LLC 1,247,428$30,325,0001.25%
Ranger Investment Management 982,240$23,878,0001.16%
HealthCor Management, L.P. 912,381$22,180,0001.12%
Piermont Capital Management Inc. 138,380$3,364,0001.02%
JW Asset Management, LLC 111,630$2,714,0000.82%
SECTORAL ASSET MANAGEMENT INC 465,625$11,319,0000.47%
ACUTA CAPITAL PARTNERS, LLC 28,000$681,0000.42%
Tekla Capital Management LLC 409,500$9,955,0000.36%
View complete list of SAGENT PHARMACEUTICALS INC shareholders